Recently, we demonstrated decreased tumor proliferation with an alteration of glucose and lipid tumor metabolism, antagonizing PPARα by synthetic ligand (GW6471) in glioblastoma stem cells (GSCs) [84]. The gene discussed is PPARA; the disease is glioblastoma.